The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Open accessAbstract
Nanotechnology, the use of materials with dimensions on the atomic or molecular scale, has become increasingly utilized for medical applications and is of great interest as an approach to kill or reduce the activity of numerous microorganisms. Infections caused by multidrug-resistant organisms (MDROs) are emerging causes of morbidity and mortality worldwide. The optimal treatment route for infections caused by MDROs is often unclear, and the antibiotic options are limited. These challenges highlight the critical demand for alternative and effective antimicrobial strategies. The physical structure of a nanoparticle itself and the way in which it interacts with and penetrates into bacteria appear to provide unique bactericidal mechanisms. Coupling nanoparticles and natural-based antimicrobials (or other repurposed compounds) to inhibit bacterial efflux pumps, biofilm formation, quorum sensing, and possibly plasmid curing, are some of the strategies to combat MDROs. Combinatorial therapy with metallic nanoparticles, as an adjunct to existing antibiotics, may aid in restraining the mounting menace of bacterial resistance. In this review, we will summarize the current researches on nanoparticles and other nanomaterials and how they are applied or can be applied in the future to fight MDROs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NPs are less likely to develop resistance compared to classical antibiotics because their bactericidal activity targets multiple mechanisms [13,14].”
From Infection Control with Antimicrobial Solid-State ZnO Nanoparticles on Silk Fibroin Gauze (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Antibacterial properties of nanoparticles
Hajipour, M. J., Fromm, K. M., Akbar Ashkarran, A., Jimenez de Aberasturi, D., Larramendi, I. R. D., Rojo, T., Serpooshan, V., Parak, W. J., & Mahmoudi, M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.06.004 · Cited by 2,710
Metal nanoparticles: understanding the mechanisms behind antibacterial activity
Slavin, Y. N., Asnis, J., Häfeli, U. O., & Bach, H. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0308-z · Cited by 2,571
Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01831 · Cited by 2,135
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Antimicrobial activity of the metals and metal oxide nanoparticles
Dizaj, S. M., Lotfipour, F., Barzegar-Jalali, M., Zarrintan, M. H., & Adibkia, K. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.08.031 · Cited by 1,725
Characterisation of copper oxide nanoparticles for antimicrobial applications
Ren, G., Hu, D., Cheng, E. W. C., Vargas-Reus, M. A., Reip, P., & Allaker, R. P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.004 · Cited by 1,604
Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity
Durán, N., Durán, M., de Jesus, M. B., Seabra, A. B., Fávaro, W. J., & Nakazato, G. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.11.016 · Cited by 1,542
Rai, M. K., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05253.x · Cited by 1,524
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview
Burdușel, A.-C., Gherasim, O., Grumezescu, A. M., Mogoantă, L., Ficai, A., & Andronescu, E. (2018) · Nanomaterials · doi:10.3390/nano8090681 · Cited by 1,343
Bondarenko, O., Juganson, K., Ivask, A., Kasemets, K., Mortimer, M., & Kahru, A. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1079-4 · Cited by 1,270
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Antimicrobial applications of nanotechnology: methods and literature
Webster, T. J., & Seil, I. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24805 · Cited by 1,010
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Silver nanoparticles: synthesis, properties, and therapeutic applications
Wei, L., Lu, J., Xu, H., Patel, A., Chen, Z.-S., & Chen, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.014 · Cited by 970
Bacterial resistance to silver nanoparticles and how to overcome it
Panáček, A., Kvítek, L., Smékalová, M., Večeřová, R., Kolář, M., Röderová, M., Dyčka, F., Šebela, M., Prucek, R., Tomanec, O., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-017-0013-y · Cited by 963
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Mechanism of antibacterial activity of copper nanoparticles
Chatterjee, A. K., Chakraborty, R., & Basu, T. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/13/135101 · Cited by 868
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., & Mukherjee, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15355f · Cited by 866
Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency
Lesniak, A., Salvati, A., Santos-Martinez, M. J., Radomski, M. W., Dawson, K. A., & Åberg, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309812z · Cited by 852
Alternative Antimicrobial Approach: Nano-Antimicrobial Materials
Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/246012 · Cited by 837
Metal‐based nanoparticles and their toxicity assessment
Schrand, A. M., Rahman, M. F., Hussain, S. M., Schlager, J. J., Smith, D. A., & Syed, A. F. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.103 · Cited by 753
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A. (2016) · Molecules · doi:10.3390/molecules21070836 · Cited by 556
Nanomaterials for alternative antibacterial therapy
Hemeg, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132163 · Cited by 550
Silver Nanoparticles: Therapeutical Uses, Toxicity, and Safety Issues
Dos Santos, C. A., Seckler, M. M., Ingle, A. P., Gupta, I., Galdiero, S., Galdiero, M., Gade, A., & Rai, M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24001 · Cited by 531
A review of mammalian toxicity of ZnO nanoparticles
Vandebriel, R., & De Jong, W. (2012) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s23932 · Cited by 494
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Lu, Z., Rong, K., Li, J., Yang, H., & Chen, R. (2013) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-013-4894-5 · Cited by 418
Ivask, A., Juganson, K., Bondarenko, O., Mortimer, M., Aruoja, V., Kasemets, K., Blinova, I., Heinlaan, M., Slaveykova, V., & Kahru, A. (2014) · Nanotoxicology · doi:10.3109/17435390.2013.855831 · Cited by 332
Cavassin, E. D., de Figueiredo, L. F. P., Otoch, J. P., Seckler, M. M., de Oliveira, R. A., Franco, F. F., Marangoni, V. S., Zucolotto, V., Levin, A. S. S., & Costa, S. F. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0120-6 · Cited by 300
Naqvi, S. Z., Kiran, U., Ali, Jamal, Hameed, Ahmed, & Ali (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49284 · Cited by 299
Lei, R., Wu, C., Yang, B., Ma, H., Shi, C., Wang, Q., Wang, Q., Yuan, Y., & Liao, M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.026 · Cited by 291
The Role of Nanotechnology in Combating Multi-Drug Resistant Bacteria
Singh, R., Smitha, M. S., & Singh, S. P. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9527 · Cited by 265
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Pharmacokinetics of metallic nanoparticles
Lin, Z., Monteiro‐Riviere, N. A., & Riviere, J. E. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1304 · Cited by 257
In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics
Saha, B., Bhattacharya, J., Mukherjee, A., Ghosh, A., Santra, C., Dasgupta, A. K., & Karmakar, P. (2007) · Nanoscale Research Letters · doi:10.1007/s11671-007-9104-2 · Cited by 255
Rapid evolution of silver nanoparticle resistance in Escherichia coli
Graves, J. L., Tajkarimi, M., Cunningham, Q., Campbell, A., Nonga, H., Harrison, S. H., & Barrick, J. E. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00042 · Cited by 250
Khan, S. T., Musarrat, J., & Al-Khedhairy, A. A. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.05.046 · Cited by 241
From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance
Natan, M., & Banin, E. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux003 · Cited by 234
Prospects of Nanostructure Materials and Their Composites as Antimicrobial Agents
Baranwal, A., Srivastava, A., Kumar, P., Bajpai, V. K., Maurya, P. K., & Chandra, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00422 · Cited by 224
Antimicrobial Effects of Biogenic Nanoparticles
Singh, P., Garg, A., Pandit, S., Mokkapati, V. R. S. S., & Mijakovic, I. (2018) · Nanomaterials · doi:10.3390/nano8121009 · Cited by 216
Antimicrobial resistance in hospitals: How concerned should we be?
Mulvey, M. R., & Simor, A. E. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080239 · Cited by 199
Nano-therapeutics: A revolution in infection control in post antibiotic era
Zaidi, S., Misba, L., & Khan, A. U. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.06.015 · Cited by 196
Multiple strategies to activate gold nanoparticles as antibiotics
Zhao, Y., & Jiang, X. (2013) · Nanoscale · doi:10.1039/c3nr01990j · Cited by 190
Emerging trends of nanomedicine – an overview
Sandhiya, S., Dkhar, S. A., & Surendiran, A. (2009) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00692.x · Cited by 174
The safety of nanocrystalline silver dressings on burns: A study of systemic silver absorption
Vlachou, E., Chipp, E., Shale, E., Wilson, Y. T., Papini, R., & Moiemen, N. S. (2007) · Burns · doi:10.1016/j.burns.2007.07.014 · Cited by 166
Antimicrobial Drugs in Fighting against Antimicrobial Resistance
Cheng, G., Dai, M., Ahmed, S., Hao, H., Wang, X., & Yuan, Z. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00470 · Cited by 165
Scandorieiro, S., de Camargo, L. C., Lancheros, C. A. C., Yamada-Ogatta, S. F., Nakamura, C. V., de Oliveira, A. G., Andrade, C. G. T. J., Duran, N., Nakazato, G., & Kobayashi, R. K. T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00760 · Cited by 161
Metal nanobullets for multidrug resistant bacteria and biofilms
Chen, C., Hsu, C., Lai, S.-M., Syu, W., Wang, T., & Lai, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.004 · Cited by 151
Bacterial responses to Cu-doped TiO2 nanoparticles
Wu, B., Huang, R., Sahu, M., Feng, X., Biswas, P., & Tang, Y. (2009) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2009.11.004 · Cited by 147
Interaction of Al2 O3 nanoparticles with Escherichia coli and their cell envelope biomolecules
Ansari, M. A., Khan, H. M., Khan, A., Cameotra, S. S., Saquib, Q., & Musarrat, J. (2013) · Journal of Applied Microbiology · doi:10.1111/jam.12423 · Cited by 143
Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)
Barros, C. H. N., Fulaz, S. F., Stanišić, D., & Tasić, L. (2018) · Antibiotics · doi:10.3390/antibiotics7030069 · Cited by 125
Gupta, A., Saleh, N. M., Das, R., Landis, R. F., Bigdeli, A., Motamedchaboki, K., Campos, A. R., Pomeroy, K., Mahmoudi, M., & Rotello, V. M. (2017) · Nano Futures · doi:10.1088/2399-1984/aa69fb · Cited by 113
Kandi, V., & Kandi, S. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015020 · Cited by 112
Physiologically Important Metal Nanoparticles and Their Toxicity
Sengupta, J., Ghosh, S., Datta, P., Gomes, A., & Gomes, A. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9078 · Cited by 111
Fakhri, A., Tahami, S., & Naji, M. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.02.014 · Cited by 73
Tsao, L.-H., Hsin, C.-Y., Liu, H.-Y., Chuang, H.-C., Chen, L.-Y., & Lee, Y. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.08.015 · Cited by 66
Ting, S.-W., Lee, C., & Liu, J.-W. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.022 · Cited by 53
Nanotoxicity: The Toxicity Research Progress of Metal and Metal- Containing Nanoparticles
Ding, L., Liu, Z., Aggrey, M. O., et al. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955751507150424104334 · Cited by 49
Nanotechnology based anti-infectives to fight microbial intrusions
Rai, M., Ingle, A. P., Gaikwad, S. C., Gupta, I. R., Gade, A., & da Silva, S. S. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.13010 · Cited by 48
Kuo, A.-J., Shu, J., Liu, T.-P., Lu, J., Lee, M., Wu, T., Su, L., & Wu, T. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.08.008 · Cited by 37
Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Leucuta, S. E. (2013) · Current Drug Delivery · doi:10.2174/1567201811310020007 · Cited by 26
Pfurtscheller, K., Petnehazy, T., Goessler, W., Bubalo, V., Kamolz, L., & Trop, M. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12209 · Cited by 18
Cited by
Silver Nanoparticles and Their Antibacterial Applications
Bruna, T., Maldonado-Bravo, F., Jara, P., & Caro, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137202 · Cited by 1,708
Rodrigues, A. S., Batista, J. G. S., Rodrigues, M. Á. V., Thipe, V. C., Minarini, L. A. R., Lopes, P. S., & Lugão, A. B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1440065 · Cited by 346
Antimicrobial nanoparticles: current landscape and future challenges
Mondal, S. K., Chakraborty, S., Manna, S., & Mandal, S. M. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00032c · Cited by 318
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
Infection Control with Antimicrobial Solid-State ZnO Nanoparticles on Silk Fibroin Gauze
Vieira, D., Dang, C.-T., Monk, R., Angel, S., Marion, A., Gbureck, U., Harvey, E., & Merle, G. (2024) · Applied Sciences · doi:10.3390/app14167103 · Cited by 9
Metadata
- Authors
- Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-10-04
- Volume
- 10
- Pages
- 1153-1153
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2978392882
- Cited by
- 532
- References
- 71
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.